Anterogen.Co.,Ltd. (KOSDAQ:A065660) announced a private placement of round 5 convertible bonds for gross proceeds of KRW 16,000,000,000 on March 5, 2021. The transaction will include participation from Shinhan-Neo Market-Frontier Fund II, a fund managed by Shinhan Venture Investment Co, Ltd. for KRW 6,000,000,000, SLi Next innovation Fund, a fund managed by SL Investment for KRW 1,600,000,000, Reun KOSDAQ Venture Hedge Fund 1 and Reun Kosdaq Venture Hedge Fund 4, funds managed by returning investor NH Investment & Securities Co., Ltd., Investment Arm for KRW 2,000,000,000 each, K Bio Fund for KRW 2,000,000,000 and SLi Quintom Growth Fund for KRW 2,400,000,000. The bonds are zero coupon bonds with no interest rate to maturity and will mature on March 08, 2024. The bonds are fully convertible into common shares at a conversion price of KRW 60,500 from March 08, 2022 to February 08, 2024. The transaction has been approved by the board of directors of the company. The subscription date and payment date is March 08, 2021.